Affiliation: Queen Mary
- Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trialSue M Moss
Wolfson Institute, Queen Mary University of London, London, UK Electronic address
Lancet Oncol 16:1123-32. 2015..Here, we report the results of the UK Age trial after 17 years of follow-up...
- The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studiesS M Moss
Centre for Cancer Prevention, Queen Mary University of London, Wolfson Institute for Preventive Medicine, London, UK
J Med Screen 19:26-32. 2012..We reviewed such studies of population-based screening in Europe to assess their value...
- European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomesS Moss
Centre for Cancer Prevention, Wolfson Institute, Queen Mary University of London, United Kingdom
Endoscopy 44:SE49-64. 2012....
- Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort studyS W Duffy
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK
Health Technol Assess 17:vii-xiv, 1-95. 2013..Up to now, this strategy has not been fully evaluated...
- Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancerJ Mackay
North East Thames Regional Genetics Service, Institute of Child Health, London, UK
J Epidemiol Biostat 6:365-9; discussion 371-5. 2001..Incremental cost-effectiveness ratios of implementing the standardised mammography strategy compared with no screening will be presented in terms of the additional cost per cancer detected, per life saved and per life-year saved...
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialWendy S Atkin
Department of Surgery and Cancer, Imperial College London, London, UK
Lancet 375:1624-33. 2010..We tested the hypothesis that only one flexible sigmoidoscopy screening between 55 and 64 years of age can substantially reduce colorectal cancer incidence and mortality...